Nikhil Verma, M.D., a sports medicine physician with Midwest Orthopaedics at Rush (MOR) in Chicago, has been named head team physician for the Chicago White Sox. As noted in the February 22, 2017 news release, Dr. Verma, director of the Division of Sports Medicine for the Department of Orthopedic Surgery at Rush University Medical Center, performs more than 600 surgical procedures annually.
Nikhil N. Verma, M.D. New Head Team Physician for Chicago White Sox
1 min read Premium comments
#Teamphysician#ChicagoWhiteSox#NikhilVermaMD#whitesox
“Dr. Verma will take over the reins for Charles Bush-Joseph, M.D., who was head team physician since 2003 and is stepping down to assume the roles as incoming president of the American Orthopaedic Society for Sports Medicine, AOSSM, and board member of Rush Health.”
“Like Dr. Bush-Joseph, Dr. Verma has a great reputation in the sports medicine industry,” said Herm Schneider, Head Athletic Trainer for the Chicago White Sox, in the February 22, 2017 news release. “In addition to his strong background in research and academics, his clinical practice focuses on providing quality orthopedic care for athletes. These skills, complemented by his calm, caring demeanor make him a strong leader of our medical team.”
Dr. Verma is also fellowship director for Sports Medicine and professor and Director of Clinical Research, Sports Medicine Section, Rush University Medical Center. He told OTW, “Fortunately we have enjoyed a mutually productive and longstanding relationship with the White Sox since 2003. During that time Dr. Bush- Joseph has developed a strong professional relationship with both management and players built on trust and professionalism. Over the last two to three years I have spent an increasing amount of time working with the team in preparation for this role and therefore expect a seamless transition.”
“As a sports medicine physician, one of the goals of our career is to provide medical care to professional athletes, to provide them with the support they need to enjoy a productive and lasting career in athletics. I look forward to this opportunity and the challenges of managing the professional athlete.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.